LENEXA, Kan.--(BUSINESS WIRE)--CyDex, Inc. announced today that it has changed its name to “CyDex Pharmaceuticals, Inc.” CyDex changed its name to reflect its current focus on developing and commercializing its pharmaceutical product candidates. Historically, CyDex’s focus had been on the licensing of its CAPTISOL® technology to pharmaceutical companies.
